Free wi-fi service launched over RailTel network: Google
Tech giant Google on Monday announced the launch of free high-speed public wi-fi service at 15 railways stations across India over the extensive fiber network of Indian Railway’s RailTel, which provides internet services as RailWire.
"We’re seeing incredible usage of the wi-fi service across the stations and over 2.5 lakhs users are using the service every week, demonstrating more than 2x growth in less than a month. Backed by this response, RailTel and the ministry of railways has decided to extend the project to cover key suburban stations in Mumbai as well," said Gulzar Azad, head of access programmes, Google India.
"The service is now live across 15 stations covering key corners of the country from Pune to Guwahati, and from Ernakulam to Jaipur. Our roll out schedule is on track and we are confident of providing the service across 100 stations in India by end of this year," added Azad.
The RailTel Google free high-speed public wi-fi service is currently available at Mumbai Central, Pune, Bhubaneshwar, Bhopal, Ranchi, Raipur, Vijayawada, Kacheguda, Ernakulum Junction, Vishakhapatnam, Jaipur, Patna, Guwahati, Ujjain and Allahabad.
Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.


Government launches app to monitor solid waste management
In a step towards simplifying waste management, the environment ministry launched a web-based application -- Integrated Waste Management System (IWMS) -- here on Monday to help in tracking the 'movement and management' of hazardous and other solid wastes.
Environment Minister Prakash Javadekar, launching the website - - said this would help them monitor total 43,000 industries responsible for producing hazardous waste.
"With this we can track all the hazardous waste and other solid waste. It will also become a single window for authorization and provide state and nation-wise data on waste generation and number of waste generating and processing industrial units," Javadekar said here.
The minister added that the data obtained will help the authorities to identify the problem areas of the waste management and plan accordingly. The portal will generate data on different categories of waste including hazardous, bio-medical, electronic, plastic and municipal waste.
"There are over 43,000 industrial units producing the hazardous waste, like the waste generated while producing nickel. Out of these, 30,000 had already been mapped using this application and other will be mapped soon," the minister said.
The portal will also facilitate the people in obtaining permission for import and export of certain categories of waste, for reuse, recycling, recovery or co-processing and conserve the primary source. 
The ministry official stated that it also aims to track the waste producing industry using Geographic Information System (GIS) maps for effective monitoring and, if required, to inspect their waste management or processing mechanism.
"The upgraded version of the IWMS is expected to encompass generation of annual report from the annual return filed by the industries for various types of waste generated in the country. This version would provide customized GIS based information. The GIS maps would be generated and integrated with underlying information to provide an excellent visual outlook to the available data," a ministry statement said.

Disclaimer: Information, facts or opinions expressed in this news article are presented as sourced from IANS and do not reflect views of Moneylife and hence Moneylife is not responsible or liable for the same. As a source and news provider, IANS is responsible for accuracy, completeness, suitability and validity of any information in this article.


Another Study Finds Link Between Pharma Money and Brand-name Prescribing

A group of researchers at Harvard Medical School has found that medical industry payments to physicians in Massachusetts are associated with higher rates of prescribing brand-name drugs that treat high cholesterol.


The study's finding, published today in JAMA Internal Medicine, is in line with a ProPublica analysis and story from March, which showed that physicians who receive industry money tend to prescribe higher rates of brand-name drugs 2014 and thus, lower rates of similarly effective, more affordable generic drugs 2014 when compared to peers.


What the New 2018Collaborative Media' Can Mean

  • Search through nearly 15 million records to see if your doctor has received money from a drug or device company. Search for your physician.
  • Get the data that powers this investigation. A complete, digital download is available for purchase in the Data Store.

An aim of the study, said lead author Dr. James S. Yeh, was to determine and reduce any industry influence that could produce bad behavior.


"You want your doctors to be objective rather than doing something because there is a financial gain, be it subconscious or conscious," Yeh said. "That's not the way we should be doing medicine."


Yeh added that not all industry relationships with physicians are problematic. Often pharmaceutical companies fund large research projects that could produce advances in medical care.


The Harvard study concluded that physicians' rate of prescribing brand-name statins 2014 the category of drugs that treat high cholesterol 2014 increased by 0.1 percent for every $1,000 in industry money received. Under $2,000 in payments, there was no significant increase in brand-name prescribing.


A 0.1 percent increase in brand-name prescribing might not seem like much, but the study notes that brand-name statins cost two to four times wholesale as much as generics and that cost is an important factor in patient health outcomes. Patients are less likely to keep taking drugs that are more expensive.


Both ProPublica and the Harvard researchers were careful not to assign a causal relationship between payments and brand-name prescribing because there's a lot that the data alone can't show 2014 for instance, why a doctor chose a certain drug, or the list of preferred drugs used by a patient's insurer. It's also possible that pharmaceutical companies market their drugs more to doctors who are already high brand-name prescribers.


"I think the causal relationship is really difficult to determine because there's so many other factors that impact the physician's prescribing behavior," said Yeh, a research fellow at Brigham and Women's Hospital and Harvard Medical School.


The Harvard study differs from ProPublica's analysis in a few ways. ProPublica looked at doctors nationwide in the five most populous specialties, using data from the U.S. Centers for Medicare and Medicaid Services' Open Payments program, which included all payments to doctors from drug and device makers in 2014. The Harvard researchers only looked at Massachusetts doctors, using a 2011 physician payment database kept by the state's department of health.


Also, ProPublica focused on overall brand-name prescribing rates, not just for statins. The researchers chose statins because they are frequently prescribed and because there are both generic and brand-name options.


Both analyses used prescribing data from Medicare's Part D program to determine physicians' brand-name prescribing rates 2014 in fact, the Harvard researchers purchased Part D data prepared for analysis by ProPublica. Part D currently provides drug coverage to nearly 41 million seniors and disabled people.


One of Yeh's co-authors, Dr. Aaron Kesselheim, provided feedback on the design of ProPublica's analysis.


ProPublica is a Pulitzer Prize-winning investigative newsroom. Sign up for their newsletter.



















We are listening!

Solve the equation and enter in the Captcha field.

To continue

Sign Up or Sign In


To continue

Sign Up or Sign In



The Scam
24 Year Of The Scam: The Perennial Bestseller, reads like a Thriller!
Moneylife Magazine
Fiercely independent and pro-consumer information on personal finance
Stockletters in 3 Flavours
Outstanding research that beats mutual funds year after year
MAS: Complete Online Financial Advisory
(Includes Moneylife Magazine and Lion Stockletter)